HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses

scientific article published on 29 November 2016

HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/TRI.12898
P698PubMed publication ID27896862

P50authorJean-Charles Duclos-ValléeQ43376312
Audrey CoillyQ56460426
Didier SamuelQ57775596
Anne-Marie Roque-AfonsoQ59683284
P2093author name stringEric Vibert
Gabriella Pittau
Eleonora De Martin
Teresa M Antonini
P2860cites workRibavirin for chronic hepatitis E virus infection in transplant recipientsQ34410881
Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United StatesQ35761385
The impact of hepatitis E in the liver transplant settingQ38246621
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With RibavirinQ40980835
A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipientsQ41757565
P433issue3
P921main subjectliver transplantationQ1368191
P304page(s)318-319
P577publication date2016-11-29
P1433published inTransplant InternationalQ15762140
P1476titleHCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses
P478volume30

Reverse relations

cites work (P2860)
Q92458456Antiviral Candidates for Treating Hepatitis E Virus Infection
Q93002309Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections
Q92569537Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response

Search more.